European Association of Cardiovascular Imaging (EACVI) survey on Cardiovascular Multimodality Imaging in Acute Myocarditis.

Acute myocarditis EACVI Survey cardiac magnetic resonance echocardiography

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
03 Apr 2024
Historique:
received: 28 03 2024
accepted: 30 03 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: aheadofprint

Résumé

To assess the current role of cardiac imaging in the diagnosis, management, and follow-up of patients with acute myocarditis (AM) through an European Association of Cardiovascular Imaging survey. A total of 412 volunteers from 74 countries responded to the survey. Most participants worked in tertiary centres(56%). All participants had access to echocardiography, while 79% and 75% had access to cardiac computed tomography (CCTA) and cardiac magnetic resonance (CMR), respectively. Less than half(47%) had access to myocardial biopsy and only 5% used this test routinely. CMR was performed within 7 days of presentation in 73% of cases. Non-ischemic late gadolinium enhancement (LGE,88%) and high-signal intensity in T2-weighted images(74%) were the most used diagnostic criteria for AM. CCTA was preferred to coronary angiography by 47% of participants to exclude coronary artery disease. Systematic prescription of beta-blockers and ACEi was reported by 38% and 32% of participants. Around a quarter of participants declared considering LGE burden as a reason to treat. Most participants (90%) reported performing a follow-up echocardiogram, while 63% scheduled a follow-up CMR. The main reason for treatment discontinuation was improvement of left ventricular ejection fraction(89%), followed by LGE regression(60%). In two-thirds of participants the decision to resume high-intensity sport was influenced by residual LGE. This survey confirms the high utilization of cardiac imaging in AM, but reveals major differences in how cardiac imaging is used and how the condition is managed between centres, underlining the need for recommendation statements in this topic.

Identifiants

pubmed: 38568982
pii: 7639839
doi: 10.1093/ehjci/jeae092
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Yohann Bohbot (Y)

Department of Cardiology, Amiens University Hospital, Amiens, France.
UR UPJV 7517, Jules Verne University of Picardie, Amiens, France.

Théo Pezel (T)

Université Paris Cité, Department of Cardiology, University Hospital of Lariboisiere, (Assistance Publique des Hôpitaux de Paris, AP-HP), 75010, Paris, France.
Inserm MASCOT - UMRS 942, University Hospital of Lariboisiere, 75010, Paris, France.
MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory and Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France.

Ahmet Demirkıran (A)

Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Cardiology, Kocaeli Sehir Medical Center, Kocaeli, Türkiye.

Emmanuel Androulakis (E)

St George's University London, UK.
Imaging Centre, Royal Brompton Hospital, Guy's St Thomas NHS Foundation Trust, London, UK.

Golnaz Houshmand (G)

Rajaie Cardiovascular, Medical and Research Centre, Iran University of Medical Sciences, Tehran, Iran.

Liliana Szabo (L)

William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, EC1A 7BE, London, UK.
Semmelweis University, Budapest, Hungary.

Robert Manka (R)

Department of Cardiology, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Simona B Botezatu (SB)

Department of Cardiology, University of Medicine and Pharmacy "Carol Davila", Euroecolab, Bucharest, Romania.
Emergency Institute for Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Bucharest, Romania.

José F Rodríguez-Palomares (JF)

Cardiovascular Imaging Unit. Cardiology Department. Hospital Universitari Vall Hebrón. Barcelona. Spain.
Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain.
CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain.

Tor Biering-Sørensen (T)

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen.
Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte.
Steno Diabetes Center Copenhagen.

Tomaz Podlesnikar (T)

Department of Cardiac Surgery, University Medical Centre Maribor, Slovenia.
Department of Cardiology, University Medical Centre Ljubljana, Slovenia.

Marc R Dweck (MR)

British Heart Foundation Centre for Cardiovascular Science, University ot Edinburgh, United Kingdom. Chancellors Buidling, Little France Crescent, Edinburgh EH16 4SB.

Classifications MeSH